IMM 11.9% 29.5¢ immutep limited

Ann: Final Phase IIb AIPAC clinical trial results for Efti in MBC, page-20

  1. 5,252 Posts.
    lightbulb Created with Sketch. 1641
    I tend to agree more consistent news glow on trials progress would be helpful and not waiting for big conferences.

    Based on reports, I underestand more news is coming by the end of this month and that will hopefully makes things clear as to what results have been, not just re AIPAC, and also hopefully before the end of the year we will have news re direction from here re AIPAC phase III (which i believe is immenant) and maybe we get some news as to how it may be funded. Based on my educated guess, it is highly likely a lot of planning had already started before SITC as most of data was reasonably known. So, hopefully some news of partnership will be in there too.

    Fingers crossed. AIMO, DYOR.

 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
29.5¢
Change
-0.040(11.9%)
Mkt cap ! $428.5M
Open High Low Value Volume
32.0¢ 33.0¢ 28.0¢ $7.278M 23.75M

Buyers (Bids)

No. Vol. Price($)
4 53192 29.5¢
 

Sellers (Offers)

Price($) Vol. No.
30.5¢ 41048 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.